CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$296,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Seshadri Vishwas −$101K Chief Executive Officer sold 2% of stake
- Alvino Mark −$88K Director sold 19% of stake
- Vazzano Joseph Walter −$47K Chief Financial Officer sold 2% of stake
- O'Malley Brendan M. −$35K SVP, Chief Legal Officer sold 2% of stake
- Vasanthavada Madhav −$25K Chief Commercial Officer sold 2% of stake
Reading 57 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-17 | Wider Todd Director | Option exercise | +50,000 | $1.28 | $64K | 476,625 |
| 2021-02-17 | Wider Todd Director | Option exercise | +30,000 | $1.28 | $38K | 506,625 |
| 2021-02-17 | Wider Todd Director | Option exercise | +50,000 | $1.28 | $64K | 566,625 |
| 2021-02-17 | Wider Todd Director | Option exercise | +19,827 | $1.28 | $25K | 576,452 |
| 2021-02-17 | Wider Todd Director | Option exercise | +20,173 | $1.28 | $26K | 596,625 |
| 2021-02-17 | Wider Todd Director | Sale | −320,000 | $2.34 | $750K | 276,625 |
| 2021-02-17 | Wider Todd Director | Option exercise · Stock Option (Right to Buy) | −100,000 | 0 | ||
| 2021-02-17 | Wider Todd Director | Option exercise · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2021-02-17 | Wider Todd Director | Option exercise · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2021-02-17 | Wider Todd Director | Option exercise · Stock Option (Right to Buy) | −30,000 | 0 | ||
| 2021-02-17 | Wider Todd Director | Option exercise · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2021-02-17 | Wider Todd Director | Option exercise · Stock Option (Right to Buy) | −19,827 | 0 | ||
| 2021-02-17 | Wider Todd Director | Option exercise · Stock Option (Right to Buy) | −20,173 | 1,345 | ||
| 2021-02-16 | SCO CAPITAL PARTNERS LLC Director | Sale | −120,000 | $2.97 | $357K | 11,239,292 |
| 2021-02-08 | SCO CAPITAL PARTNERS LLC Director | Sale | −240,000 | $3.01 | $723K | 11,359,292 |
| 2021-01-19 | SCO CAPITAL PARTNERS LLC Director | Sale | −207,117 | $2.08 | $431K | 11,599,292 |
| 2021-01-15 | SCO CAPITAL PARTNERS LLC Director | Sale | −81,283 | $2.02 | $164K | 11,806,409 |
| 2021-01-14 | SCO CAPITAL PARTNERS LLC Director | Sale | −31,600 | $2.00 | $63K | 11,887,692 |
| 2021-01-04 | Wider Todd Director | Sale | −33,876 | $1.54 | $52K | 276,625 |
| 2021-01-04 | Mann Paul Elliot Director | Sale | −30,488 | $1.54 | $47K | 132,664 |
Page 13 of 23 · 443 trades